We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.

X

Latest Post

February 06, 2017

NovaPure® Plungers for Biologic Applications

Modern biopharmaceutical drug molecules are often complex protein structures that need to maintain the molecular structure in order to convey full potency. With biologics, any alteration of the 3-D structure could lead to loss of activity or even to immunogenic reactions in the patient. Proteins can be disrupted by interactions with the container closure or with leachables. West FluroTec® lamination was chosen for NovaPure® plungers to reduce the interaction between the drug product and elastomer material. This includes less adsorption to the plunger surface as well as reduction of the leachables profile of the plunger, helping to maintain the stability of complex molecules.
Christa Jansen-Otten

Christa Jansen-Otten, Director, Product Management

Petra Huhn, Manager, TCS Europe

Previous Posts
West stoppers

January 28, 2016

Modern Drugs Deserve Modern Packaging

West Pharma

Jay Stephens, Ph.D.

Senior Technical Account Specialist

Blue West logo with Diamond

March 16, 2015

Plunger Selection Critical for Dose Accuracy and Efficacy

Tibor Hlobik

Tibor Hlobik

Sr. Director, Marketing, PFS

Blue West logo with Diamond

June 16, 2014

Reducing Foreign Matter in Drug Products

Royce Brockett

Royce Brockett

Sr. Manager, Marketing, PFS

Blue West logo with Diamond

December 02, 2013

Why is QbD so Confusing?

West Pharma

Whitney Winters

Director, Sales, Emering Biologics

QbD  CQA  FEA  NovaPure  Quality  QTTP 
Load more